PharmaShots | Incisive News in 3 Shots

Subscribe Now

VYNE Therapeutics

VYNE Therapeutics Reports the US FDA’s Acceptance of IND for VYN202 to Treat Autoimmune Diseases

VYNE Therapeutics Reports the US FDA’s Acceptance of IND for VYN202 to Treat Autoimmune Diseases

May 7, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us